Page last updated: 2024-11-05

triazolam and Chorea

triazolam has been researched along with Chorea in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Chorea: Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Kroef, C1

Other Studies

1 other study available for triazolam and Chorea

ArticleYear
Reactions to triazolam.
    Lancet (London, England), 1979, Sep-08, Volume: 2, Issue:8141

    Topics: Anti-Anxiety Agents; Chorea; Humans; Muscle Tonus; Psychoses, Substance-Induced; Syndrome; Triazolam

1979